当前位置：
X-MOL 学术
›
Aliment. Pharm. Ther.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Editorial: risk of loss of response to anti-TNFα agents in patients with inflammatory bowel disease—the longer the less?
Alimentary Pharmacology & Therapeutics ( IF 7.6 ) Pub Date : 2021-12-30 , DOI: 10.1111/apt.16648 Idan Goren 1, 2 , Henit Yanai 1, 2
Alimentary Pharmacology & Therapeutics ( IF 7.6 ) Pub Date : 2021-12-30 , DOI: 10.1111/apt.16648 Idan Goren 1, 2 , Henit Yanai 1, 2
Affiliation
This article is linked to Schultheiss et al papers. To view these articles, visit https://doi.org/10.1111/apt.16605 and https://doi.org/10.1111/apt.16722
中文翻译：
社论：炎症性肠病患者对抗 TNFα 药物失去反应的风险——时间越长越少？
本文链接到 Schultheiss 等人的论文。要查看这些文章，请访问 https://doi.org/10.1111/apt.16605 和 https://doi.org/10.1111/apt.16722
更新日期：2021-12-31
中文翻译：
社论：炎症性肠病患者对抗 TNFα 药物失去反应的风险——时间越长越少？
本文链接到 Schultheiss 等人的论文。要查看这些文章，请访问 https://doi.org/10.1111/apt.16605 和 https://doi.org/10.1111/apt.16722
京公网安备 11010802027423号